immigrant; late diagnosis; NBS; phenylketonuria; refugee; phenylalanine; adolescent; adult; Article; asymptomatic disease; autism; child; developmental delay; epilepsy; Europe; false negative result; family; female; health program; health survey; human; inborn error of metabolism; infant; major clinical study; male; missed diagnosis; newborn; newborn screening; North America; Pacific islands; patient referral; questionnaire; symptom; Syrian Arab Republic; delayed diagnosis; global health; health care delivery; health care policy; health care survey; migrant; organization and management; preschool child; young adult; Adolescent; Adult; Child; Child, Preschool; Delayed Diagnosis; Emigrants and Immigrants; Female; Global Health; Health Care Surveys; Health Policy; Health Services Accessibility; Humans; Infant; Infant, Newborn; Male; Neonatal Screening; Phenylketonurias; Young Adult
van Wegberg, A.M.J.; Division of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands
Trefz, F.; Dietmar Hopp Metabolic Center, University Children's Hospital, Heidelberg, Germany
Gizewska, M.; Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases, and Cardiology of the Developmental Age, Pomeranian Medical University, Szczecin, Poland
Ahmed, S.; Section of Chemical Pathology, Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan
Chabraoui, L.; Central Laboratory of Biochemistry, University Hospital Ibn Sina of Rabat, Rabat, Morocco, Faculty of Pharmacy, University Euromed of Fez, Fez, Morocco
Zaki, M.S.; Human Genetics and Genome Research Division, Clinical Genetics Department, National Research Center, Cairo, Egypt, Egypt
Maillot, F.; Internal Medicine Department, University Hospital of Tours, UMR INSERM 1253 “iBrain”, Tours, France
van Spronsen, F.J.; Division of Metabolic Diseases, Beatrix Children's Hospital, University Medical Center Groningen, Groningen, Netherlands
Ahring, K.
Al Mutairi, F.
Arnoux, J.B.
Ballhausen, D.
Baruteau, J.
Bernstein, L.
Bijarnia-Mahay, S.
Boemer, François ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Undiagnosed Phenylketonuria Can Exist Everywhere: Results From an International Survey
Publication date :
2021
Journal title :
Journal of Pediatrics
ISSN :
0022-3476
eISSN :
1097-6833
Publisher :
Elsevier Inc.
Volume :
239
Pages :
231 - 234.e2
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
A.v.W. has received a research grant from Nutricia , honoraria from Biomarin as speaker, and travel support from Nutricia and Vitaflo . M.G. has been a member of the scientific advisory boards of Merck-Serono SA, and Biomarin and has received honoraria as a consultant and/or speaker for Biomarin, Merck Serono SA, Nutricia, and Vitaflo. F.M. has been a member of scientific advisory boards for PKU of APR, Arla Food International, and BioMarin; has received research grants from Biomarin ; and has received honoraria as consultant and speaker from Biomarin and Vitaflo. F.T. has received grants from Vitaflo Germany and honoraria as a speaker for Merck-Serono SA. F.v.S. is a member of scientific advisory boards for PKU and amino acid defects that are supported by Agios , Applied Pharma Research , Arla Food International , BioMarin , Eurocept , Homology , Lucane , Nestle-Codexis Alliance , Nutricia , Orphan Europe , Rivium Medical BV , and Vivet ; has received research grants from Alexion , BioMarin , Beatrix Research Fund , Codexis , ESPKU , NPKUA , NPKUV , Nutricia , Sobi , Tyrosinemia Foundation , Vitaflo , and ZonMw ; and has received honoraria as a consultant and speaker from Applied Pharma Research, Biomarin, MendeliKABS, Nutricia, Orphan Europe, Pluvia Biotech, SoBi, and Vitaflo. The other authors declare no conflicts of interest.
Therrell, B.L., Padilla, C.D., Loeber, J.G., Kneisser, I., Saadallah, A., Borrajo, G.J.C., et al. Current status of newborn screening worldwide: 2015. Semin Perinatol 39 (2015), 171–187.
Giżewska, M., MacDonald, A., Bélanger-Quintana, A., Burlina, A., Cleary, M., Coşkun, T., et al. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results. Eur J Pediatr 175 (2016), 261–272.
Karam, P.E., Daher, R.T., Moller, L.B., Mikati, M.A., Experience with hyperphenylalaninemia in a developing country: unusual clinical manifestations and a novel gene mutation. J Child Neurol 26 (2011), 142–146.
Yıldız, Y., Dursun, A., Tokatli, A., Coşkun, T., Sivri, H.S., Late-diagnosed phenylketonuria in an eight-year-old boy with dyslexia and attention-deficit hyperactivity disorder. Turk J Pediatr 58 (2016), 94–96.
Trefz, F., Maillot, F., Motzfeldt, K., Schwarz, M., Adult phenylketonuria outcome and management. Mol Genet Metab 104:Suppl (2011), S26–S30.
Schiergens, K.A., Staudigl, M., Borggraefe, I., Maier, E.M., Neurological sequelae due to inborn metabolic diseases in pediatric refugees: challenges in treating the untreated. Neuropediatrics 49 (2018), 363–368.
Mazlum, B., Anlar, B., Kalkanoğlu-Sivri, H.S., Karlı-Oğuz, K., Özusta, S., Ünal, F., A late-diagnosed phenylketonuria case presenting with autism spectrum disorder in early childhood. Turk J Pediatr 58 (2016), 318–322.
Vela-Amieva, M., Ibarra-González, I., Fernández-Lainez, C., Monroy-Santoyo, S., Guillén-López, S., Belmont-Martínez, L., et al. Causes of delay in referral of patients with phenylketonuria to a specialized reference centre in Mexico. J Med Screen 18 (2011), 115–120.
Razeghi, S., Renner, C., Überall, M.A., Wenzel, D., Spätdiagnose einer Phenylketonurie bei einem 21/2 Jahre alten Mädchen. Monatsschr Kinderheilkd, 146, 1998, 3 (in German).
Sinai, L.N., Kim, S.C., Casey, R., Pinto-Martin, J.A., Phenylketonuria screening: effect of early newborn discharge. Pediatrics 96:4 Pt 1 (1995), 605–608.
Yang, I.L., Mao, H.Q., Zhang, W.F., Zhao, Z.Y., Yang, R.L., Zhou, X.L., et al. Pitfalls in the management of phenylketonuria in China. HK J Paediatr 17 (2012), 143–147.
van Vliet, D., van Wegberg, A.M.J., Ahring, K., Bik-Multanowski, M., Blau, N., Bulut, F.D., et al. Can untreated PKU patients escape from intellectual disability? A systematic review. Orphanet J Rare Dis, 13, 2018, 149.
van Vliet, D., van Wegberg, A.M.J., Ahring, K., Bik-Multanowski, M., Casas, K., Didycz, B., et al. Untreated PKU patients without intellectual disability: what do they teach us?. Nutrients, 11, 2019, 2572.
van Spronsen, F.J., van Wegberg, A.M., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A.M., et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 5 (2017), 743–756.
van Wegberg, A.M.J., MacDonald, A., Ahring, K., Bélanger-Quintana, A., Blau, N., Bosch, A.M., et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis, 12, 2017, 162.
Brown, M.C., Guest, J.F., Economic impact of feeding a phenylalanine-restricted diet to adults with previously untreated phenylketonuria. J Intellect Disabil Res 43:Pt 1 (1999), 30–37.
Lee, P.J., Amos, A., Robertson, L., Fitzgerald, B., Hoskin, R., Lilburn, M., et al. Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet. J Neurol Neurosurg Psychiatry 80 (2009), 631–635.
Ganji, F., Naseri, H., Rostampour, N., Sedighi, M., Lotfizadeh, M., Assessing the phenylketonuria screening program in newborns, Iran 2015-2016. Acta Med Iran 56 (2018), 49–55.
Mütze, U., Garbade, S.F., Gramer, G., Lindner, M., Freisinger, P., Grünert, S.C., et al. Long-term outcomes of individuals with metabolic diseases identified through newborn screening. Pediatrics, 146, 2020 e20200444.
Alfadhel, M., Al Othaim, A., Al Saif, S., Al Mutairi, F., Alsayed, M., Rahbeeni, Z., et al. Expanded newborn screening program in Saudi Arabia: incidence of screened disorders. J Paediatr Child Health 53 (2017), 585–591.
Sadek, A.A., Hassan, M.H., Mohammed, N.A., Clinical and neuropsychological outcomes for children with phenylketonuria in Upper Egypt; a single-center study over 5 years. Neuropsychiatr Dis Treat 14 (2018), 2551–2561.
Graham, H.R., Minhas, R.S., Paxton, G., Learning problems in children of refugee background: a systematic review. Pediatrics, 137, 2016 e20153994.
Kaplan, I., Stolk, Y., Valibhoy, M., Tucker, A., Baker, J., Cognitive assessment of refugee children: effects of trauma and new language acquisition. Transcult Psychiatry 53 (2016), 81–109.
Miller, A., Hess, J.M., Bybee, D., Goodkind, J.R., Understanding the mental health consequences of family separation for refugees: implications for policy and practice. Am J Orthopsychiatry 88 (2018), 26–37.
Tinghög, P., Malm, A., Arwidson, C., Sigvardsdotter, E., Lundin, A., Saboonchi, F., Prevalence of mental ill health, traumas and postmigration stress among refugees from Syria resettled in Sweden after 2011: a population-based survey. BMJ Open, 7, 2017 e018899.
Zerjav Tansek, M., Groselj, U., Angelkova, N., Anton, D., Baric, I., Djordjevic, M., et al. Phenylketonuria screening and management in southeastern Europe—survey results from 11 countries. Orphanet J Rare Dis, 10, 2015, 68.
